1	Abnormal	abnormal	_	_	_	_	_	_	_
2	regulation	regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	IL-2	il-2	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	lpr	lpr	_	_	_	_	_	_	_
9	CD4-CD8-	cd4-cd8-	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	results	result	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	constitutive	constitutive	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	novel	novel	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	factor	factor	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	activated	activate	_	_	_	_	_	_	_
23	T	t	_	_	_	_	_	_	_
24	cells-binding	cells-binding	_	_	_	_	_	_	_
25	factor	factor	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	inert	inert	_	_	_	_	_	_	_
3	quality	quality	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	MRL-Ipr/Ipr	MRL-Ipr/Ipr	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	Ipr	Ipr	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	peripheral	peripheral	_	_	_	_	_	_	_
10	CD4-CD8-	cd4-cd8-	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	CD4-8-	cd4-8-	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	manifests	manifest	_	_	_	_	_	_	_
17	primarily	primarily	_	_	_	_	_	_	_
18	as	as	_	_	_	_	_	_	_
19	an	an	_	_	_	_	_	_	_
20	inability	inability	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	proliferate	proliferate	_	_	_	_	_	_	_
23	or	or	_	_	_	_	_	_	_
24	produce	produce	_	_	_	_	_	_	_
25	IL-2	il-2	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	response	response	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	TCR	TCR	_	_	_	_	_	_	_
30	or	or	_	_	_	_	_	_	_
31	mitogenic	mitogenic	_	_	_	_	_	_	_
32	stimulation	stimulation	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Yet	yet	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	same	same	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	do	do	_	_	_	_	_	_	_
6	initiate	initiate	_	_	_	_	_	_	_
7	early	early	_	_	_	_	_	_	_
8	TCR-mediated	tcr-mediated	_	_	_	_	_	_	_
9	signaling	signaling	_	_	_	_	_	_	_
10	events	event	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	such	such	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	generation	generation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	inositol	inositol	_	_	_	_	_	_	_
17	phosphates	phosphate	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	increased	increase	_	_	_	_	_	_	_
20	intracellular	intracellular	_	_	_	_	_	_	_
21	calcium	calcium	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	They	they	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	display	display	_	_	_	_	_	_	_
4	constitutively	constitutively	_	_	_	_	_	_	_
5	high	high	_	_	_	_	_	_	_
6	levels	level	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	p59fyn	p59fyn	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	CD3	cd3	_	_	_	_	_	_	_
11	zeta	zeta	_	_	_	_	_	_	_
12	tyrosine	tyrosine	_	_	_	_	_	_	_
13	phosphorylation	phosphorylation	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	generation	generation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	second	second	_	_	_	_	_	_	_
5	messengers	messenger	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	normally	normally	_	_	_	_	_	_	_
10	leads	lead	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	downstream	downstream	_	_	_	_	_	_	_
13	signaling	signaling	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	results	result	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	transcriptional	transcriptional	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	IL-2	il-2	_	_	_	_	_	_	_
22	gene	gene	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	therefore	therefore	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	compared	compare	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	state	state	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	promoter	promoter	_	_	_	_	_	_	_
14	region	region	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	freshly	freshly	_	_	_	_	_	_	_
17	isolated	isolate	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	stimulated	stimulate	_	_	_	_	_	_	_
20	Ipr	Ipr	_	_	_	_	_	_	_
21	CD4-8-	cd4-8-	_	_	_	_	_	_	_
22	T	t	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	with	with	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	normal	normal	_	_	_	_	_	_	_
28	T	t	_	_	_	_	_	_	_
29	lymphocytes	lymphocyte	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Levels	level	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	octamer	octamer	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	p50-p65	p50-p65	_	_	_	_	_	_	_
10	heterodimer	heterodimer	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	AP-1	ap-1	_	_	_	_	_	_	_
15	transcriptional	transcriptional	_	_	_	_	_	_	_
16	factors	factor	_	_	_	_	_	_	_
17	are	be	_	_	_	_	_	_	_
18	constitutively	constitutively	_	_	_	_	_	_	_
19	elevated	elevate	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	freshly	freshly	_	_	_	_	_	_	_
22	isolated	isolate	_	_	_	_	_	_	_
23	Ipr	Ipr	_	_	_	_	_	_	_
24	CD4-8-	cd4-8-	_	_	_	_	_	_	_
25	T	t	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	consistent	consistent	_	_	_	_	_	_	_
29	with	with	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	activated	activate	_	_	_	_	_	_	_
32	phenotype	phenotype	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	these	these	_	_	_	_	_	_	_
35	cells	cell	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Upon	upon	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	mitogens	mitogen	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	formation	formation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	transactivating	transactivate	_	_	_	_	_	_	_
10	complex	complex	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	nuclear	nuclear	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	activated	activate	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	NF-AT	NF-AT	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	occurs	occur	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	normal	normal	_	_	_	_	_	_	_
25	kinetics	kinetic	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	Ipr	Ipr	_	_	_	_	_	_	_
28	CD4-8-	CD4-8-	_	_	_	_	_	_	_
29	T	t	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Yet	yet	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	levels	level	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	activating	activate	_	_	_	_	_	_	_
8	NF-AT	nf-at	_	_	_	_	_	_	_
9	complex	complex	_	_	_	_	_	_	_
10	never	never	_	_	_	_	_	_	_
11	reach	reach	_	_	_	_	_	_	_
12	those	those	_	_	_	_	_	_	_
13	observed	observe	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	similarly	similarly	_	_	_	_	_	_	_
16	stimulated	stimulate	_	_	_	_	_	_	_
17	normal	normal	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	extracts	extract	_	_	_	_	_	_	_
5	from	from	_	_	_	_	_	_	_
6	Ipr	Ipr	_	_	_	_	_	_	_
7	CD4-8-	CD4-8-	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	display	display	_	_	_	_	_	_	_
11	high	high	_	_	_	_	_	_	_
12	levels	level	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	novel	novel	_	_	_	_	_	_	_
16	specific	specific	_	_	_	_	_	_	_
17	binding	binding	_	_	_	_	_	_	_
18	activity	activity	_	_	_	_	_	_	_
19	at	at	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	NF-AT	NF-AT	_	_	_	_	_	_	_
22	site	site	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	which	which	_	_	_	_	_	_	_
25	is	be	_	_	_	_	_	_	_
26	present	present	_	_	_	_	_	_	_
27	at	at	_	_	_	_	_	_	_
28	much	much	_	_	_	_	_	_	_
29	lower	low	_	_	_	_	_	_	_
30	levels	level	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	freshly	freshly	_	_	_	_	_	_	_
33	isolated	isolate	_	_	_	_	_	_	_
34	normal	normal	_	_	_	_	_	_	_
35	T	t	_	_	_	_	_	_	_
36	lymphocytes	lymphocyte	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Upon	upon	_	_	_	_	_	_	_
2	mitogenic	mitogenic	_	_	_	_	_	_	_
3	stimulation	stimulation	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	binding	binding	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	novel	novel	_	_	_	_	_	_	_
11	NF-AT-binding	nf-at-binding	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	rapidly	rapidly	_	_	_	_	_	_	_
15	down-regulated	down-regulate	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	normal	normal	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	but	but	_	_	_	_	_	_	_
22	persists	persist	_	_	_	_	_	_	_
23	at	at	_	_	_	_	_	_	_
24	high	high	_	_	_	_	_	_	_
25	levels	level	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	Ipr	Ipr	_	_	_	_	_	_	_
28	CD4-8-	CD4-8-	_	_	_	_	_	_	_
29	T	t	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	two	two	_	_	_	_	_	_	_
3	abnormalities	abnormality	_	_	_	_	_	_	_
4	at	at	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	NF-AT	NF-AT	_	_	_	_	_	_	_
7	site	site	_	_	_	_	_	_	_
8	provide	provide	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	potential	potential	_	_	_	_	_	_	_
11	mechanism	mechanism	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	account	account	_	_	_	_	_	_	_
14	for	for	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	defect	defect	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	production	production	_	_	_	_	_	_	_
20	from	from	_	_	_	_	_	_	_
21	Ipr	Ipr	_	_	_	_	_	_	_
22	CD4-8-	CD4-8-	_	_	_	_	_	_	_
23	T	t	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

